Home Members Daniele Piovani

Daniele Piovani

Assistant Professor

Medical Statistics

Assistant Professor

E-mail

daniele.piovani@humanitasresearch.it

Education

2003–2009 Bachelor’s degree in Chemistry and Pharmaceutical Technologies(Laurea Magistrale, 5-year course),Faculty of Pharmacy, University of Bologna, Bologna, Italy.
2009–2010 Master of Science (M.Sc.) in Clinical Research,University of Milan, Faculty of Medicine, Milan, Italy.
2010–2018 Research Fellowship, Istituto di Ricerche Farmacologiche “Mario Negri”, Department of Public Health, Laboratory for Mother and Child Health, Pharmacoepidemiology Unit, Milan, Italy.
2014–2018 Ph.D. in Epidemiology,Open University, Walton Hall, Kents Hill, Milton Keynes, United Kingdom.Title: “Determinants of Drug Utilisation During Childhood

Present academic appointment

Assistant Professor of Medical Statistics (MED/01)

Academic background

2018–2022 Post-doctoral Research Fellow in Medical Statistics (Assegnista di Ricerca, art. 22, legge n. 240/2010),Department of Biomedical Sciences,Humanitas UniversityMilan, Italy.

Teaching appointments

2020–2023 Integrated course: “Ricerca, Evidenza Scientifica e Sistemi di Valutazione& delle Attività Sanitarie”, for the Master Degree (Laurea Magistrale) in “Scienze Infermieristiche ed Ostetriche”. (12 hours of teaching per academic year; SSD: MED/01), Humanitas University, Milan, Italy.

Academic honors, awards and prices

Award for the study: “The procoagulant effect of COVID-19 on the thrombotic risk of patients with hip fractures” (in Greek language), by Tsantes et al. (including D. Piovani), Panhellenic Congress for the 90 years of the Greek Society of Microbiology, 28–30 January 2022, Athens, Greece.
Recognition for the study: “Environmental Risk Factors for Inflammatory Bowel Diseases: an Umbrella Review of Meta-analyses” (first author D. Piovani) published in Gastroenterology (IF: 33.883). It was chosen by the Editors in chief to be part of the Continuing Medical Education for Readers program and to have accompanying CME exercises.
Recognition for the study: “Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy”, by Cecconi et al. (second and corresponding author D. Piovani). It was chosen by the Editors in chief of Journal of Clinical Medicine (IF: 4.964) as “Editor’s choice” for the particular interest and importance in the field.
The publication: “Compassionate use of remdesivir in COVID-19”, by Bonovas, S., Piovani, D. published on the New England Journal of Medicine 2020; 382:e101. (Impact factor: 176.079) was cited in a press release by “POLITICO” on the 22/05/2020.

His research activities pertain to clinical epidemiology, study of risk factors and prognostic factors of diseases, pharmacoepidemiology, safety of drugs and evidence synthesis (through systematic reviews, meta-analyses and umbrella reviews). He has gained experience as a GRADE methodologist and was part of the team of methodologists who contributed to develop the GRADE-based pioneer edition of the European Ulcerative Colitis Treatment Guidelines, European Crohn’s & Colitis Organization (ECCO) and the Italian IG-IBD guidelines on the use of biologics and small molecules in inflammatory bowel diseases. His activity as a biostatistician concentrates on applied biostatistical methods such as multivariable analyses and statistical learning tools, development and validation of prognostic models, causal inference analyses through propensity score methods, decision curve analyses, planning and analysis of observational and randomized studies.

Piovani, D., Christodoulou, M.N., Hadjidemetriou, A., Pantavou, K., Zaza, P., Bagos, P.G., Bonovas, S., Nikolopoulos, G.K. Effect of early application of social distancing interventions on Covid-19 mortality over the first pandemic wave: an analysis of longitudinal data from 37 countries. Journal of Infection 2020; 82:133-142. DOI: 10.1016/j.jinf.2020.11.033.
Piovani, D., Danese, S., Peyrin-Biroulet, L., Nikolopoulos, G.K., Lytras, T., Bonovas, S. Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses. Gastroenterology 2019; 157:647-659.e4. DOI: 10.1053/j.gastro.2019.04.016.
Tursi, A., Brandimarte, G., Di Mario, F., Elisei, W., Picchio, M., Allegretta, L., Annunziata, M. L., Bafutto, M., Bassotti, G., Bianco, M. A., Colucci, R., Conigliaro, R., Dumitrascu, D., Escalante, R., Ferrini, L., Forti, G., Franceschi, M., Graziani, M. G., Lammert, F., Latella, G., Maconi, G., Nardone, G., de Castro Oliveira, L.C., Chaves Oliveira, E., Papa, P., Papagrigoriadis, S., Pietrzak, A., Pontone, S., Poskus, T., Pranzo, G., Reichert, M.C., Rodinò, S., Regula, J., Scaccianoce, G., Scaldaferri, F., Vassallo, R., Zampaletta, C., Zullo, A., Piovani, D., Bonovas, S., Danese S. Prognostic performance of the ‘DICA’ endoscopic classification and the ‘CODA’ score in predicting clinical outcomes of diverticular disease: an international, multicentre, prospective cohort study. Gut 2021; 71:1350-1358. DOI:10.1136/gutjnl-2021-325574.
Piovani, D., Hassan, C., Repici, A., Rimassa, L., Carlo-Stella, C., Nikolopoulos, K. N., Riboli, E., Bonovas, S. Risk of cancer in inflammatory bowel diseases: umbrella review and re-analysis of meta-analyses. Gastroenterology 2022; S0016-508500529-7. Advance online publication. DOI:10.1053/j.gastro.2022.05.038
Piovani, D., Bonovas, S. Study of critically ill patients with COVID-19 in New York City. The Lancet 2020; 396:1064.